BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2031 related articles for article (PubMed ID: 19443319)

  • 1. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
    Moczygemba LR; Barner JC; Roberson K
    J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
    ;
    J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
    Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
    Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
    Winston S; Lin YS
    J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
    Shoemaker SJ; Hassol A
    J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
    Luder HR; Frede SM; Kirby JA; Epplen K; Cavanaugh T; Martin-Boone JE; Conrad WF; Kuhlmann D; Heaton PC
    J Am Pharm Assoc (2003); 2015; 55(3):246-54. PubMed ID: 26003155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.